Skip to content
Research Article Open access CC BY 3.0

Problems and Perspectives in Diagnosis and Prevention of Ovarian Tumor Diseases

Petr G. Prokopenko, Valentina Poltoranina, Kirill I. Zhordania, Olga Petrenko, Innokenty M. Mokhosoev, Alexander A. Terentiev

Journal of Advances in Medicine and Medical Research · pp. 182–197 · Published 29 May 2011

10.9734/BJMMR/2011/344

Abstract

A set of embryonic proteins - potential markers for ovarian tumors is presented. More than ten new embryonic proteins have been tested, but no one strictly specific protein marker for diagnosis of ovarian tumors has been revealed. SOVA-1 is the most perspective marker for today. The special attention is given to peculiarities of evolution and mechanisms of early distribution of the tumor process. The role of pregnancy and “pregnancy specific glycoprotein”- PSG as a way of the ovary tumor disease prevention is discussed. An attempt to realize sources and logic of the disease is undertaken in the present work.

Ovarian tumor - peculiarities of evolution and progress embryonic proteins- perspectives of immunodiagnostics pregnancy specific glycoprotein (PSG) pregnancy as prevention measure in case of ovarian tumor disease

References (20)

  1. 1 Reactivity of a monoclonal antibody with human ovarian carcinoma. [DOI]
  2. 2 INCESSANT OVULATION—A FACTOR IN OVARIAN NEOPLASIA ? [DOI]
  3. 3 Pregnancy-specific -1-glycoprotein 1 and human leukocyte antigen-E mRNA in human sperm: differential expression in fertile and infertile men and evidence of a possible functional role during early development [DOI]
  4. 4 Risk Factor for Ovarian Cancer [DOI]
  5. 5 Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases [DOI]
  6. 6 Albumin-IgG complexes in human serum and plasma that inhibit blood platelet adhesion. [DOI]
  7. 7 Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer.
  8. 8 Benign ovarian tumors.
  9. 9 Identification and Characterization of Serum Protein in Patients with Ovarian Cancer [DOI]
  10. 10 [Determination of ferroproteins in biological fluids].
  11. 11 Purification and Characterization [DOI]
  12. 12 Development of a radioimmunoassay for pregnancy‐specific beta1‐globulin and its measurement in serum of patients with trophoblastic and non‐trophoblastic tumours [DOI]
  13. 13 Ovarian tumor-specific antigens [DOI]
  14. 14 Immunochemical identification of carcinoembryonic antigen in extracts of ovarian adenocarcinoma and pseudomucinous cystoma [DOI]
  15. 15 [Clinico-morphological characteristics of marginal epithelial ovarian tumors].
  16. 16 Immunochemical identification of ferritin and its immunologic analogs ?-fetoprotein and ?2H-globulin [DOI]
  17. 17 Antigenic Structure of Ovarian Cancer Metastases [DOI]
  18. 18 [Significance of genome research methods in diagnosis and therapy of ovarian carcinoma].
  19. 19 [Ferritin study in tumors of the female genitalia].
  20. 20 [Immunoenzyme analysis of ovarian metastatic antigen-8].

Cited by 4

Ascitic Antigen CA125: Study of Dissociaton Forms and its Final - Stem Structure

Petr G. Prokopenko, Olga Petrenko, Valentina Shelepova, Vadim V. Negrebetsky, Innokenty M. Mokhosoev, Аlexander А. Terentiev · Journal of Advances in Medicine and Medical Research · 2013

Recombinant N-Domain of Pregnancy-Specific Glycoprotein from E. coli Cells: Analysis of the Spectrum of Polyclonal Antibodies

P. G. Prokopenko, A. N. Shkoporov, O. Yu. Petrenko · Bulletin of Experimental Biology and Medicine · 2015

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

22

Page views

0

PDF downloads

3

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.